Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model
Author(s) -
Sebastian Wurster,
Russell E. Lewis,
Nathaniel D. Albert,
Dimitrios P. Kontoyiannis
Publication year - 2018
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01896-18
Subject(s) - mucorales , aspergillus fumigatus , voriconazole , virulence , biology , mucormycosis , aspergillus , microbiology and biotechnology , aspergillosis , drosophila melanogaster , virology , medicine , immunology , antifungal , genetics , pathology , gene
Breakthrough mucormycosis in patients receiving isavuconazole prophylaxis or therapy has been reported. We compared the impact of isavuconazole and voriconazole exposure on the virulence of clinical isolates ofAspergillus fumigatus and differentMucorales species in aDrosophila melanogaster infection model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom